Skip to main content
. 2017 Mar 10;10(1):29. doi: 10.3390/ph10010029

Table 2.

Biodistribution data of [68Ga]Ga-TRAP(NT4)3 expressed as percent injected dose per gram tissue (%ID/g) ± standard deviation of 2–3 HT29 tumor-bearing nude mice for each time point.

Organ 60 min 90 min 60 min Blocking 1 60 min Blocking 2
blood 0.13 ± 0.02 0.04 ± 0.02 0.07 ± 0.01 0.40 ± 0.01
lung 2.76 ± 0.53 2.37 ± 0.21 1.61 ± 0.42 6.06 ± 1.19
liver 11.18 ± 0.30 11.71 ± 0.48 8.30 ± 0.87 11.21 ± 2.27
kidney 94.55 ± 10.84 102.37 ± 29.88 96.26 ± 8.83 99.91 ± 15.52
heart 0.13 ± 0.02 0.35 ± 0.37 0.15 ± 0.11 0.45 ± 0.13
spleen 3.72 ± 0.09 3.45 ± 0.38 2.20 ± 0.39 3.75 ± 0.81
brain 0.04 ± 0.01 0.02 ± 0.01 0.06 ± 0.07 0.07 ± 0.02
muscle 0.09 ± 0.03 0.11 ± 0.08 0.10 ± 0.05 0.16 ± 0.03
femur 1.51 ± 0.12 1.17 ± 0.21 0.74 ± 0.14 1.72 ± 0.12
HT29 tumor 1.74 ± 0.21 1.44 ± 0.13 1.10 ± 0.20 0.60 ± 0.13
intestine 1.50 ± 0.42 1.31 ± 0.20 0.49 ± 0.08 0.49 ± 0.07

1 Co-injection of [68Ga]Ga-TRAP(NT4)3 and TRAP(NT4)3 (20 nmol per mouse); 2 Co-injection of [68Ga]Ga-TRAP(NT4)3 and NT4 (100 nmol per mouse).